The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Review of Domestic Research on Korean Medicine for Pancreatic Cancer

췌장암에 대한 국내 한의학 연구 동향 고찰 - 국내 한의학 논문을 중심으로 -

  • Received : 2019.03.07
  • Accepted : 2019.03.29
  • Published : 2019.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study investigated the trends in pancreatic cancer research on Korean medicine in order to establish a direction for further study. Methods: Pancreatic cancer research on Korean medicine was reviewed using databases such as OASIS, KoreanTK, KISS, RISS, KISTI, and NDSL. The search terms were "pancreatic cancer" "Korean medicine," and "herbal medicine." There was no restriction on publication dates, and the reviewed studies were analyzed according to the type of research. Results: Nineteen studies were reviewed. The numbers and types of research were as follows: 9 clinical studies including case reports, 2 review studies, and 8 in vitro studies; there was no in vivo study. Among the clinical research were 3 descriptive studies and 6 case reports. The baseline characteristics and quality of life of pancreatic cancer patients were analyzed in the descriptive studies. In the case reports, interventions such as herbal medicine, pharmacopuncture, and acupuncture were used. Research articles on the review of pancreatic cancer were titled "Preliminary Study for Development of Korean Medicine Clinical Practice Guideline for Pancreatic Cancer" and "Systemic Review on the Tumor Dormancy Therapy." Cell lines such as PANC-1, MIA PaCa-2, and AsPC-1 were used for in vitro studies. These studies have reported decreased cell viability, induced apoptosis, and changes in cancer-related gene expression. Conclusion: Through this review, we found that using Korean medicine for treating pancreatic cancer is applicable. However, due to overall limited the number of study, the benefit of Korean medicine for pancreatic cancer may be substantiated to a limited degree. Better methodological quality and large controlled trials are expected to further quantify the therapeutic effect of Korean medicine.

Keywords

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29. https://doi.org/10.3322/caac.20138
  2. National Center Information Cancer [Internet]. Goyang-si, Republic of Korea: Ministry of Health and Welfare; [cited 2019 Feb 20]. Available from: https://www.cancer.go.kr
  3. American cancer society [Internet]. Atlanta, Georgia, USA: (C) 2019 American Cancer Society, Inc; [cited 2019 Feb 20]. Available from: https://www.cancer.org /research/cancer-facts-statistics/allcancer-facts-figures/ cancer-facts-figures-2018.html
  4. National Comprehensive Cancer Network [internet]. Plymouth Meeting, USA: National Comprehensive Cancer Network;[cited 2019 Jan 20]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf
  5. Bang SM. Surveillance and early diagnosis of pancreatic cancer. The Korean Journal of Pancreas and Biliary Tract2015;20(1):1-4. https://doi.org/10.15279/kpba.2015.20.1.1
  6. Kim JW. Recent treatment of pancreatic cancer. Korean J Med 2009;77(6):695-702.
  7. Ryu JK. Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer. Korean J Gastroenterol2015;66(3):150-3. https://doi.org/10.4166/kjg.2015.66.3.150
  8. Park JG, Bang YJ, Ha SH. Oncology. Seoul: Iljogak; 2012, p. 317-8, 327-9, 330-1.
  9. Bang SM. Novel Therapeutic Modalities for Metastatic Pancreatic Cancer. Korean J Pancreas Biliary Tract 2016;21(4):185-90. https://doi.org/10.15279/kpba.2016.21.4.185
  10. Lee BM, Min HJ, Ahn P, Park SH, Han SW, Kim DY, et al. A Case of Near Complete Response in Metastatic Pancreatic Cancer after Gemcitabine Chemotherapy. Korean J Pancreas and Biliary Tract 2013;18(1):46-50.
  11. Jang SO. Gemcitabine plus Capecitabine versus Gemcitabine Alone as First-line Therapy for Patients with Advanced or Metastatic Pancreatic Cancer : Efficacy and Economic Evaluation [master's thesis]. Seoul(Republic of Korea): Ewha Women's University; 2010, p. 6, 14, 15.
  12. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc2010;42(7):1409-26. https://doi.org/10.1249/MSS.0b013e3181e0c112
  13. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001;19(14):3306-10. https://doi.org/10.1200/JCO.2001.19.14.3306
  14. Li M, Wang MM, Guo XW, Wu CY, Li DR, Zhang X, et al. Different Survival Benefits of Chinese Medicine for Pancreatic Cancer: How to Choose? Chin J Integr Med 2018;24(3):178-84. https://doi.org/10.1007/s11655-017-2971-1
  15. Levy MH, Adolph MD, Back A, Block S, Codada SN, Dalal S, et al. Palliative care. J Natl Compr Canc Netw2012 Oct 1;10(10):1284-309. https://doi.org/10.6004/jnccn.2012.0132
  16. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology Provisional Clinical Opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012;30(8):880-7. https://doi.org/10.1200/JCO.2011.38.5161
  17. Li B, Gan R, Yang QJ, Huang JL, Chen PG, Wan LL, Guo C. Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2015;2015:350730.
  18. Han GJ, Son JY, Seong S, Kim SS. Review of Domestic Research on Traditional Korean Medicine for Breast Cancer. J Int Korean Med 2018;39(1):44-68. https://doi.org/10.22246/jikm.2018.39.1.44
  19. Han GJ, Shin HG, Seong S, Kim SS. Systematic Review of Case Reports about Korean Medicine for Lung cancer. J Korean Med 2018;39(4):136-57. https://doi.org/10.13048/jkm.18041
  20. Kang YH, Hong MN, Han CW, Choi JY, Park SH, Kim SY. Review on Clinical Studies of Traditional Herbal Medicine and Acupuncture Treatments for Colorectal Cancer Patients. J Physiol & Pathol Korean Med2016;30(4):219-28. https://doi.org/10.15188/kjopp.2016.08.30.4.219
  21. Lee JE, Choi JY, Han CW, Choi JY, Park SH, Kim SY. A Review on Experimental Research about Anticancer Drug Combined Treatment with Herbal Medicine for Killing or Inhibiting Proliferation of Cancer cells in Korea. J of The Korean Medicine Society For The Herbal Formula Study 2017;25(3):391-412.
  22. Kim JH, Park DS, Kim YS, Lee JD. Review on Clinical Study of Oriental Medical Treatment for Cancer in Korea. J of Korean acupuncture & moxibustion medicine society2012;29(3):19-28.
  23. Choi CM, Koh BH, Kim SH, Choi WC, Lee SK. A Study on Quality of Life of Advanced Hepatobiliary and Pancreatic Cancer patients Administered with Traditional Korean Cancer Treatment. J Korean Oriental Med 2008;29(4):30-8.
  24. Kim KS. A study of allergen removed Rhus Verniciflua Stokes treated for metastatic pancreatic adenocarcinoma [master' thesis]. Kyunghee University 2010.
  25. Kang HJ. Alterations and Correlations Analysis of Natural Killer Cell Activity and Systemic Inflammatory Markers for Gastric, Breast and Pancreatic Cancer Patients Treated with Wheel Balance Cancer Therapy [dissertation]. Daejeon University2016.
  26. Park SE, Seo SH, Hong SH, Kim JY, Shin WT, Youn HM, et al. A Case of Dyspnea in Pancreatic cancer Treated through Herbal Acupunture Treatment. Journal of Pharmacopuncture 2006;9(1):59-67. https://doi.org/10.3831/KPI.2006.9.1.059
  27. Bang SH, Lee JH, Cho JH, Lee YW, Son CG, Cho CK, et al. A Case Report of Pancreatic Cancer Treated With Lymph Node Metastasis. Korean J Orient Int Med 2007;28(4):978-85.
  28. Yoon HY, Cho CK, Yoo HS, Bang SH. A Case Report of Unresectable Pancreatic Carcinoma Patient for Relieving Cancer Related Pain and Improving Quality of Life by Korean Medical Treatment. J of Kor Traditional Oncology 2013;18(1):9-15. https://doi.org/10.15432/JKTO.2013.18.1.009
  29. Seo SH, Yoo HS, Lee YY, Song KC, Choi BL, Cho JH, et al. A case of cholangiocarcinoma patient with pancreas metastasis. Korean J Orient Int Med2002;23(4):735-40.
  30. Kim JM, Park JW, Yoo HS, Lee YW, Cho CK. Case Report of the Pancreatic Cancer Patient after Pancreatoduodenectomy who is Taking the HangAm-Plus to Anti-metastasis and Preventing Recurrence. J of Kor Traditional Oncology 2011;16(1):33-9. https://doi.org/10.15432/JKTO.2011.16.1.033
  31. Park DW, Jang IK. Pancreatic cancer. J of East-West Med1980;5(1):51-3.
  32. Park SJ, Yoo HS, Yu JS. Preliminary Study for Development of Korean Medicine Clinical Practice Guideline for Pancreatic Cancer. J of Kor Traditional Oncology 2017;22(1):1-11. https://doi.org/10.15432/JKTO.2017.22.1.001
  33. Lee JH. Systemic Review on the Tumor Dormancy Therapy [master's thesis]. Daejeon University 2011.
  34. Kim H, Won JH, Moon G. Anti-cancer Effects of Bujeonghangamtang on Human Pancreatic Cancer Cell Line PANC-1. Korean J of Oriental Medical Prescription2007;15(1):213-28.
  35. Baek DG. Effects of Paljinhangahm-dan on Cell Cycle Arrest and Apoptosis in Human Pancreatic Cancer Cell Line PANC-1 [dissertation]. Wonkwang University 2007.
  36. Kang BH. Effect of Herbal Mixture Extract (H3) on Cancer Stem Cells and Apoptosis of Pancreatic Cancer Cell Line [master's thesis]. Korea University 2015.
  37. Kang YK, Choi JU, Lee EA, Jang HS, Lee JM, Park HR. Cytotoxic Effects of Leaves of Cudrania tricuspidata Bureau Extracts on Human Pancreatic Cancer Cells. J of cancer prevention2011;16(4):333-9.
  38. Hong JY, Park HR, Kwon YG, Kwon WY, Kim SY, Park RD, et al. Anticancer Properties of Astilbe rubra Extracts on AsPC-1 Human Pancreatic Cancer Cells. J of basic science 2015;32:21-8.
  39. Lee IY, Jeong HS, Won JH. Apoptotic Effect of Phellodendri Cortex Water Extract on MIA PaCa-2 Cells. Korean J Oriental Physiology & Pathology2013;27(2):202-11.
  40. Kim SJ. Effects of Myrrha on Pancreatic Cancer Cells [master's thesis]. Wonkwang University 2013.
  41. Joo HA, Bae HJ, Hwang CY. Apoptotic Effect of ARTEMISIAE CAPILLARIS HERBA and COPTIDIS RHIZOMA Extracts on MIA PaCa-2 Cells. J Korean Med Ophthalmol Otolaryngol Dermatol2014;27(4):158-76. https://doi.org/10.6114/jkood.2014.27.4.158
  42. Lee C, He H, Jiang Y, Di Y, Yang F, Li J, et al. Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis. Med Oncol 2013;30(4):700. https://doi.org/10.1007/s12032-013-0700-y
  43. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. NEJM 2014;371(11):1039-49. https://doi.org/10.1056/NEJMra1404198
  44. Lee NH, Cho JH, Son CG, Yoo HS, Lee YW, Yoon DH, et al. Analysis of Studies on Quality of Life according to Cancer Types and Symptoms. Korean J Orient Int Med 2006;27(3):555-60.
  45. Lee EH, Park HB, Kim MW, Kang SH, Lee HJ, Lee WH, et al. Analyses of the Studies on Cancer-Related Quality of Life Published in Korea. Radiat Oncol J 2002;29(4):359-66.
  46. Cho CK. Wheel Balance Cancer Therapy : Patient-centered balance therapy to inhibit metastasis and recurrence. Asan: Dajeong Books; 2015, p. 14-5.
  47. Yoo HS, Cho CK, Hong MS. Review of the best case series methodology: best case series results of East-West Cancer Center. Integr Cancer Ther 2008;7(3):182-8. https://doi.org/10.1177/1534735408322844
  48. Park HM, Kim SY, Jung IC, Lee YW, Cho CK, Yoo HS. Integrative Tumor Board: A Case Report and Discussion From East-West Cancer Center. Integrative Cancer Therapies 2010;9(2):236-45. https://doi.org/10.1177/1534735410371479
  49. Park JS, Yoo HS, Lee YW, Cho JH, Son CG, Cho CK. Wheel Balance Cancer Therapy in the Treatment of Metastatic Gastric Carcinoma: A Retrospective Analysis of 62 Patients. Korean J Int Med2000;28(3):531-43.
  50. Zheng HM, Yoon JW, Yoo HS, Cho CK. Evidence based approach of wheel balance cancer therapy; A Review. J of Kor Traditional Oncology 2012;17(2):1-16. https://doi.org/10.15432/JKTO.2012.17.2.001
  51. Kitts DD, Lim KT. Antitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes. J Toxicol Environ Health A2001;64(4):357-71. https://doi.org/10.1080/152873901316981330
  52. Kim JH, Go HY, Jin DH, Kim HP, Chung WY, Park JH, et al. Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett 2008;265(2):197-205. https://doi.org/10.1016/j.canlet.2008.02.039
  53. Lee JH, Choi WC, Yoon SW, Ko SG, Ahn KS, Lieske JC, et al. Rhus verniciflua Stokes prevents cisplatin-induced cytotoxicity and reactive oxygen species production in MDCK-I renal cells and intact mice. Phytomedicine 2009;16(2-3):188-97. https://doi.org/10.1016/j.phymed.2008.10.009
  54. Kim JH, Jung CH, Jang BH, Go HY, Park JH, Choi YK, et al. Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua Stokes. Am J Chin Med 2009;37(3):609-20. https://doi.org/10.1142/S0192415X09007090
  55. Kim KS, You HS, Jung TY, Lee YW, Cho CK. Case Series of Advanced or Metastatic Gallbladder Cancer Patients Treated with Hang-Am-Dan. Journal of Korean Oriental Internal Medicine2010;31(3):667-74.
  56. Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS, Choi SJ. Antitumor effect of HangAm-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cancer cell lines. J Korean Oriental Med 2009;30(5):50-60.
  57. Yoo HS, Kim SH, Lee YH, Cho CK, Lee KH. Two cases of endometrial cancer treated with palliative herbal medication Hangam-dan (HAD). J Korean Oriental Med 2007;28(4):176-80.
  58. Bang JY, Kim EY, Shim TK, et al. Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B). a Korean traditional medicine, using antibody microarray chip. BioChip 2010;4(4):350-5. https://doi.org/10.1007/s13206-010-4412-5
  59. Lee HJ, Lee G. YOO HS. Toxicological Study on Hang-Am-Plus in Mice. J Acupunct Meridian Stud 2011;4(1):54-60. https://doi.org/10.1016/S2005-2901(11)60007-1
  60. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004;291(9):1092-9. https://doi.org/10.1001/jama.291.9.1092
  61. Nie J, Zhao C, Deng LI, Chen J, Yu B, Wu X, et al. Efficacy of traditional Chinese medicine in treating cancer. Biomedical reports 2016;4(1):3-14. https://doi.org/10.3892/br.2015.537
  62. Saif MW. Is there a role for herbal medicine in the treatment of pancreatic cancer? Jop 2008;9(4):403-7.
  63. Cho CK, Fukuda W, Park SY. Cancer Dormancy Therapy. Asan: Dajeong Books; 2005, p. 15-31, 75-92, 93-116, 118-27, 134-51, 169-74.
  64. American Type Culture Collection [Internet]. Manassas, Verginia, USA: ATCC(R) ; [cited 2019 Mar 4]. Available from: https://www.atcc.org/products/all/CRL-1469.aspx#generalinformation
  65. American Type Culture Collection [Internet]. Manassas, Verginia, USA: ATCC(R) ; [cited 2019 Mar 4]. Available from: https://www.atcc.org/products/all/CRL-1420.aspx
  66. American Type Culture Collection [Internet]. Manassas, Verginia, USA: ATCC(R) ; [cited 2019 Mar 27]. Available from: https://www.atcc.org/products/all/CRL-1420.aspx
  67. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5):646-74. https://doi.org/10.1016/j.cell.2011.02.013
  68. Yin H, Zhu M. Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases. Free Radic Res 2012;46(8):959-74. https://doi.org/10.3109/10715762.2012.676642
  69. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35(4):495-516. https://doi.org/10.1080/01926230701320337
  70. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9(6):1799-805.
  71. Li P, Zhou L, Zhao T, Liu X, Zhang P, Liu Y, et al. Caspase-9: structure, mechanisms and clinical application. Oncotarget 2017;8(14):23996-4008. https://doi.org/10.18632/oncotarget.15098
  72. Hiraoka D, Aono R, Hanada S, Okumura E, Kishimoto T. Two new competing pathways establish the threshold for cyclin-B-Cdk1 activation at the meiotic G2/M transition. J Cell Sci 2016;129(16):3153-66. https://doi.org/10.1242/jcs.182170
  73. Petak I, Houghton JA. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res 2001;7(2):95-106. https://doi.org/10.1007/BF03032574
  74. Yadav N, Kumar S, Marlowe T, Chaudhary AK, Kumar R, Wang J, et al. Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents. Cell Death Dis 2015 Nov 5;6:e1969. https://doi.org/10.1038/cddis.2015.305
  75. Kim BJ. Experimental study about the Anti-tumor Effects of Bujeonghangamtang. [master's thesis]. Wonkwang University 1997.
  76. Leem MR, Moon SD, Moon G, Won TH, Jeon BH. The Effects of Bujeonghangamtang on antitumor Immune Response. J Korean Oriental Med 1998;19(1):234-50.
  77. Lee GU, Moon SJ, Moon G, Won JH, Kim DW, Kim HG, et al. The Effect of Paljinhangahm-dan on Human Promyelocytic Leukemia Cells(HL-60) Death. Korean J of Orienrtal Physiology & Pathology2002;16(3):514-20.
  78. Baek DG. Anticancer effect of Paljinhangahm-dan in Human Acute Myeloid Leukemia[master's thesis]. Wonkwang University 2002.
  79. Baek Ek, Moon G, Won JH, Kim DU, Baek DG, Yoon JC, et al. Anticancer Effect of Combination with Paljinhangahm-dan and Adriamycin on HepG2 Human Malignant Hepatoma Cell Line. Korean J of Orienrtal Physiology & Pathology2003;17(5):1243-50.
  80. Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, et al. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 2000;148(1):19-25. https://doi.org/10.1016/S0304-3835(99)00264-5
  81. Zhou H, Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther 2000;294(3):822-9.
  82. Lee MJ, Park JW, Kim DS. Antioxidant and Nitrite Scavenging Activity of Water-Extract from Phellodendron amurense Rupr. J Physiol & Pathol Korean Med1999;13(1):112-9.
  83. Kim EG, Kim DI, Lee TG. Studies on dosedependent anticancer and immune-enhancing activity of Phellodendri Cortex. The Journal of Oriental Obstetrics & Gynecology2002;15(2):19-30.
  84. Park JK, Jo OH, Kim SB, Cho HB. Myrrhainduced Apoptosis in Human Cervical Carcinoma HeLa Cells. J of Oriental Gynecology 2006;19(1):97-110.
  85. Kang DI, Kim SH, Shim BS, Choi SH, Ahn KS. Study on the inhibitory Effect of Molyaksan (沒藥散) on Angiogenesis. Korean J of Orienrtal Physiology & Pathology2000;14(2):91-107.

Cited by

  1. 항암화학요법과 통합의학치료를 병행하여 부분 관해 된 간전이 동반 말기 췌장암 1례 vol.41, pp.2, 2019, https://doi.org/10.22246/jikm.2020.41.2.166